These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4965342)

  • 1. [Specificity of the cell-injuring reaction (CIR) by bacteria. 2. Difference between cancer and non-cancer cells in the CIR].
    Shimizu R; Tanaka J; Yabuki Y; Hatano M
    Igaku To Seibutsugaku; 1967 May; 74(5):299-302. PubMed ID: 4965342
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specificity of the cell-injuring reaction (CIR) by bacteria--Difference between cancer and non-cancer cells in the CIR].
    Hatano M; Shimizu R; Morita O; Yamagishi T
    Igaku To Seibutsugaku; 1967 May; 74(5):293-8. PubMed ID: 4864337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specificity of cell-injuring reaction (CIR) by bacteria--differences in the reaction between cancer and non-cancer cells. 3. Time factors in the CIR measurement in the Y-27-Ehrlich ascites cancer cells and effects of the cell concentration].
    Hatano M; Shimizu R; Morita O
    Igaku To Seibutsugaku; 1967 Jun; 74(6):319-21. PubMed ID: 4965718
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specificity of cell-injuring reaction (CIR) by bacteria--differences in the reaction between cancer and non-cancer cells. 5. Identification of OD 260 mmm. substance released from the cell in the Y-27-ES system].
    Hatano M; Tanaka J; Yabuki Y; Shimizu R
    Igaku To Seibutsugaku; 1967 Jun; 74(6):361-6. PubMed ID: 4965719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Specificity of cell-injuring reaction (CIR) by bacteria--differences in the reaction between cancer and non-cancer cells. 4. Various cell conditions effecting the CIR measurement].
    Shimizu R; Morita O; Miyata S; Yabuki Y; Tanaka J
    Igaku To Seibutsugaku; 1967 Jun; 74(6):322-7. PubMed ID: 5624891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specificity of the cell-injuring reaction (CIR) by bacteria--differences in the reaction of cancer and non-cancer cells. 6. Morphological observations on Ehrlich ascites tumor cell injuries by Streptococcus (Su strain)].
    Shimizu R; Ueda H; Hatano M
    Igaku To Seibutsugaku; 1967 Aug; 75(2):37-42. PubMed ID: 5626155
    [No Abstract]   [Full Text] [Related]  

  • 7. CIR (cell injuring reaction) active substances in culture fluid of Bacillus cereus "MS-1063 strain".
    Tanaka J; Shimizu R; Hatano M
    Jpn J Med Sci Biol; 1970 Oct; 23(5):336-9. PubMed ID: 4993666
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of CIR (cell injuring reaction) active substance in culture fluid of Bacillus cereus, "MS-1063 strain".
    Tanaka J; Shimizu R; Hatano M
    Jpn J Med Sci Biol; 1971 Feb; 24(1):77-81. PubMed ID: 4996372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of the antimicrobial properties and antineoplastic effect of the new pentaenic antibiotic 661].
    Rossolimo OK; Ivanitskaia LP; Kovsharova IN; Konstantinova NV; Lavrova MF
    Antibiotiki; 1969 Sep; 14(9):849-52. PubMed ID: 4982966
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a Bacillus cereus 504 culture on the development of homologous strain cells].
    Gashinskiĭ VV; Voĭtsekhovskiĭ VG; Kuz'minskiĭ SN
    Mikrobiol Zh; 1978; 40(1):98-100. PubMed ID: 416328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differentiation of aerobic spore-forming bacteria with special reference to Bacillus anthracis and Bacullus thuringiensis].
    Krieg A
    Zentralbl Bakteriol Orig; 1970; 213(1):63-8. PubMed ID: 4989311
    [No Abstract]   [Full Text] [Related]  

  • 12. [Capillary through-flow camera for cultivation of microorganizms which are unable to actively attach].
    Gabe DR; Troshanov EP
    Mikrobiologiia; 1967; 36(1):168-75. PubMed ID: 4976142
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible adsorption of exopenicillinase on Bacillus cereus 569 cells.
    Csányi V; Mile I; Romhányi T; Hortobágyi P; Hatfaludi F
    Acta Microbiol Acad Sci Hung; 1971; 18(3):137-48. PubMed ID: 5005043
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of tumor cells for the primary screening of antineoplastic antibiotics].
    Ivanitskaia LP; Makukho LV
    Antibiotiki; 1969; 14(3):221-5. PubMed ID: 5409249
    [No Abstract]   [Full Text] [Related]  

  • 15. New method for differentiating members of the Bacillus cereus group: collaborative study.
    Harmon SM
    J Assoc Off Anal Chem; 1982 Sep; 65(5):1134-9. PubMed ID: 6813307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On growth of cancer cells in media in which glucose is replaced by galactose].
    Warburg O; Geissler AW; Lorenz S
    Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1686-7. PubMed ID: 5586915
    [No Abstract]   [Full Text] [Related]  

  • 17. Nutrition of mouse ascites tumor cells in primary culture. I. Large molecular substances and conditioned media.
    Morgan JF
    J Natl Cancer Inst; 1970 Mar; 44(3):623-31. PubMed ID: 11515431
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversibility of ouabain induced inhibition of cell division and cation transport in Ehrlich ascites cells.
    Mayhew E; Levinson C
    J Cell Physiol; 1968 Aug; 72(1):73-5. PubMed ID: 5692691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Demonstration of inhibitors in bacteriological meat examination and the significance for the consumer].
    Gemmer H; Seeger H
    Dtsch Tierarztl Wochenschr (1946); 1970 Nov; 77(22):577-80. PubMed ID: 4990988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of riboflavin and delta-aminolevulinic acid on growing cancer cells in vitro].
    Warburg O; Geissler AW; Lorenz S
    Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1683-5. PubMed ID: 5586914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.